Literature DB >> 2296088

Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers.

M A Rey1, A G Laurent, J McClure, B Krust, L Montagnier, A G Hovanessian.   

Abstract

An 80-kilodalton glycoprotein (gp80) was produced in human immunodeficiency virus type 2 (HIV-2)-infected cells along with three envelope glycoproteins that we have recently reported: the extracellular glycoprotein (gp125), the envelope glycoprotein precursor (gp140), and the transient dimeric form of the precursor (gp300). gp125 and gp80 were detectable after the synthesis of gp140 and the formation of gp300. Using a specific monoclonal antibody, we showed here that gp80 is a dimeric form of the transmembrane glycoprotein gp36 of HIV-2. Dimerization of the envelope glycoprotein precursor and dimeric forms of the transmembrane glycoproteins were also observed in cells infected with simian immunodeficiency virus (SIV-mac), a virus closely related to HIV-2. Under routine conditions of our experiments (i.e., extraction by 1% Triton X-100 before polyacrylamide gel electrophoresis in sodium dodecyl sulfate [SDS]), monomeric forms of the transmembrane glycoprotein of HIV-2 and SIV-mac were only seldomly observed. Dimeric forms of the envelope precursors and the transmembrane glycoproteins are probably stabilized by extraction in the nonionic detergent Triton X-100 since such dimeric forms resist dissociation during subsequent electrophoresis in the presence of the ionic detergent SDS. However, the dissociation of these dimeric forms might occur when samples are prepared by extraction directly in 1% SDS or by incubation of the purified dimers at acidic pH. Dimerization of the envelope precursor might be required for its processing to give the mature envelope proteins, whereas the transmembrane dimer might be essential for optimal structure of the virion and thus its infectivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296088      PMCID: PMC249191     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus.

Authors:  L H Gosting; J McClure; E S Dickinson; S M Watanabe; K Shriver; L C Goldstein
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

3.  Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer.

Authors:  D C Wiley; J J Skehel; M Waterfield
Journal:  Virology       Date:  1977-06-15       Impact factor: 3.616

4.  Oligomeric structure of a prototype retrovirus glycoprotein.

Authors:  D Einfeld; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Identification of simian immunodeficiency virus SIVMAC env gene products.

Authors:  F D Veronese; B Joseph; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing.

Authors:  M A Rey; B Krust; A G Laurent; L Montagnier; A G Hovanessian
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

8.  Autophosphorylation of the protein kinase dependent on double-stranded RNA.

Authors:  J Galabru; A Hovanessian
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.

Authors:  L Chakrabarti; M Guyader; M Alizon; M D Daniel; R C Desrosiers; P Tiollais; P Sonigo
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

View more
  18 in total

1.  Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.

Authors:  R J Center; P Schuck; R D Leapman; L O Arthur; P L Earl; B Moss; J Lebowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles.

Authors:  C D Weiss; J A Levy; J M White
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.

Authors:  M A Rey-Cuillé; J L Berthier; M C Bomsel-Demontoy; Y Chaduc; L Montagnier; A G Hovanessian; L A Chakrabarti
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.

Authors:  S S Chen; S F Lee; H J Hao; C K Chuang
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.

Authors:  P Poumbourios; W el Ahmar; D A McPhee; B E Kemp
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Authors:  Paolo Abada; Beth Noble; Paula M Cannon
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 7.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

8.  Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.

Authors:  Q J Sattentau; J P Moore; F Vignaux; F Traincard; P Poignard
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus.

Authors:  D P Knowles; W P Cheevers; T C McGuire; A L Brassfield; W G Harwood; T A Stem
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Human foamy virus polypeptides: identification of env and bel gene products.

Authors:  M L Giron; F Rozain; M C Debons-Guillemin; M Canivet; J Peries; R Emanoil-Ravier
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.